Breast Neoplasms: all 12,820 studies
Page 120 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Breast Cancer Associated AntibodiesStatus unknownNCT00331942
- ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant TreatmentCompletedNCT00331097Phase 3
- Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast CancerCompletedNCT00330317Phase 3
- Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast CancerCompletedNCT00329940Phase 3
- Protocol for Postmenopausal Women at Increased Risk of Developing Breast CancerWithdrawnNCT00329017
- A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/MastectomyCompletedNCT00328432Phase 1
- Faslodex 500mg Multiple Dose Tolerability Study in BC PatientsCompletedNCT00328120Phase 1
- Faslodex Advanced Breast Cancer Local Chinese StudyCompletedNCT00327769Phase 3
- Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast CancerCompletedNCT00327743Phase 1/2
- Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer PatientsCompletedNCT00327288Phase 1
- Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast CancerStatus unknownNCT00326820Phase 3
- Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCISWithdrawnNCT00324714Phase 3
- Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days RegimenStatus unknownNCT00324610Phase 1/2
- Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantTerminatedNCT00324324Phase 3
- Protocol to Examine Methylation of Tumor Suppression Genes in Women at High Risk of Developing Breast CancerCompletedNCT00323908
- Expanded Breast Cancer Registry and Tissue RepositoryCompletedNCT00322894
- Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast CancerCompletedNCT00322517Phase 2
- Acupuncture for Anxiety in Women With Breast Cancer: A Feasibility StudyCompletedNCT00322504Not applicable
- Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast CancerCompletedNCT00322400Phase 1
- Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast CancerCompletedNCT00321633Phase 2
- Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast CancerCompletedNCT00319618Phase 2
- Lapatinib and Doxorubicin Hydrochloride Liposome in Treating Patients With Metastatic Breast CancerCompletedNCT00316875Phase 1
- Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or AnastrozoleCompletedNCT00316836
- Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer PatientsCompletedNCT00316407Phase 1/2
- Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer.CompletedNCT00314977Phase 3
- Identification of Sentinel Lymph Nodes With Methylene Blue and IsotopeCompletedNCT00314405Not applicable
- Lapatinib and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00313599Phase 1
- Evaluation of a New Agent for Treatment of Advanced Stage Breast CancerCompletedNCT00313248Phase 2
- Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of DiseaseWithdrawnNCT00312637Not applicable
- Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By SurgeryCompletedNCT00311636Phase 3
- Involvement of Endogenous Digitalis-like Compounds in Breast CancerWithdrawnNCT00310882
- AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast CancerCompletedNCT00310089Not applicable
- Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or AcquaintanceCompletedNCT00309933
- Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast CancerStatus unknownNCT00309920Not applicable
- Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative PatientsCompletedNCT00309569Phase 3
- Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast CancerCompletedNCT00309556Phase 3
- Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive PatientsCompletedNCT00309491Phase 3
- Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive PatientsCompletedNCT00309478Phase 3
- Dose Dense Abraxane in Adjuvant Chemotherapy for Breast CancerCompletedNCT00308178Not applicable
- Does a Single Steroid Injection Reduce the Formation of Postmastectomy SeromaStatus unknownNCT00307606Phase 4
- Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1)CompletedNCT00307229Phase 1
- A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1CompletedNCT00306631Phase 2
- Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By SurgeryCompletedNCT00305825Phase 2
- Insulin Resistance and Breast CancerCompletedNCT00304941
- Polyamine-free Diet to Prevent Post Surgery HyperalgesiaCompletedNCT00304850Phase 2
- Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast CancerCompletedNCT00303992Phase 2
- Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal CancerCompletedNCT00303914
- Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are OverweightCompletedNCT00303875Phase 2
- Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast CancerTerminatedNCT00303615Phase 2
- Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal PatientsCompletedNCT00303524Phase 2
- The MONET - Study: MR Mammography of Nonpalpable Breast TumorsStatus unknownNCT00302120Phase 4
- Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By SurgeryStatus unknownNCT00301925Phase 3
- Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous TrastuzumabCompletedNCT00301899Phase 2
- S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the BoneWithdrawnNCT00301886Phase 3
- Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the LungCompletedNCT00301730Phase 1
- Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast CancerCompletedNCT00301548Phase 2
- Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast CancerCompletedNCT00301457Phase 3
- Biological Therapy in Treating Women With Breast Cancer That Has Spread to the LiverTerminatedNCT00301106Phase 1
- Radiation Therapy in Treating Women With Invasive Breast CancerCompletedNCT00301041Early Phase 1
- 3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast CancerCompletedNCT00300508Phase 3
- Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast CancerCompletedNCT00299286Phase 2
- Brief Smoking Intervention for Women Undergoing Breast Cancer SurgeryCompletedNCT00299117Not applicable
- Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast CancerTerminatedNCT00296010Phase 3
- GenetiKiT: Evaluation of an Educational Intervention on the Delivery of Genetics Services by Family PhysiciansCompletedNCT00295529Not applicable
- Tamoxifen-MRI StudyCompletedNCT00295100Phase 2
- Trial of Myocet in Metastatic Breast CancerStatus unknownNCT00294996Phase 3
- Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by GemcitabineCompletedNCT00294385Phase 3
- Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate CancerStatus unknownNCT00294151Phase 3
- Study of Sentinel Lymph Node Assessment Following Previous Surgical Biopsy for Early Breast CancerCompletedNCT00293865Not applicable
- Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With ExemestaneCompletedNCT00291798Phase 2
- ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.CompletedNCT00291759Phase 3
- Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast CarcinomaTerminatedNCT00291304Phase 2
- An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast CancerCompletedNCT00291122
- Protocol for Postmenopausal Women at Increased Risk of Developing Breast CancerCompletedNCT00291083
- Hospital Based Group Intervention for Breast Cancer Patients.CompletedNCT00289432Not applicable
- Maintenance Chemotherapy in Metastatic Breast CancerStatus unknownNCT00289263Phase 3
- Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast CancerCompletedNCT00288249Phase 2
- Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00288002Phase 3
- Telephone-Based Genetic Counseling or Standard Genetic Counseling in Women at Risk of Carrying the BRCA1 or BRCA2 MutationCompletedNCT00287898Not applicable
- Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.CompletedNCT00287534Phase 2
- Breast Cancer Screening Via Computer V. PhoneCompletedNCT00287040Phase 3
- Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast CancerCompletedNCT00286819Phase 2
- Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast CancerCompletedNCT00286247Phase 2
- ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 YearsCompletedNCT00286117Phase 3
- Caelyx Adjuvant in Elderly Breast CancerCompletedNCT00284336Phase 2
- Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast CancerCompletedNCT00283608
- Identification of a Screening Tool and Treatment of Lymphedema Secondary to the Management of Breast Cancer StudyTerminatedNCT00282529Not applicable
- RAPID: Randomized Trial of Accelerated Partial Breast IrradiationCompletedNCT00282035Not applicable
- Letrozole in Postmenopausal Women at Increased Risk for Breast CancerStatus unknownNCT00280930Phase 2
- Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast CancerCompletedNCT00279448Phase 3
- Avon Foundation Program to Improve Quality of Life in Breast Cancer SurvivorsCompletedNCT00278837Not applicable
- Improving Communication With Patients With Breast CancerTerminatedNCT00276822Not applicable
- Identification of Novel Genetic Factors That Contribute to Risk for Breast CancerCompletedNCT00276120
- Irinotecan and Cetuximab in Treating Patients With Metastatic Breast CancerCompletedNCT00275041Phase 2
- An Intervention to Decrease Fatigue Among Breast Cancer SurvivorsCompletedNCT00273208Not applicable
- SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast CancerCompletedNCT00272740Phase 2
- CT-2103 in Combination With Gemcitabine in Metastatic Breast CancerCompletedNCT00270907Phase 1
- An Effective and Compliance Regimen of Paclitaxel Plus Cisplatin to Treat Metastatic Breast CancerStatus unknownNCT00270569Phase 2
- Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer.CompletedNCT00270491Phase 2
- SU11248 as Consolidation After Response to Taxanes in Metastatic Breast CancerCompletedNCT00270413Phase 2